chr7-117314731-A-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003391.3(WNT2):​c.588+340T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.424 in 152,004 control chromosomes in the GnomAD database, including 14,045 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 14045 hom., cov: 32)

Consequence

WNT2
NM_003391.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0500

Publications

14 publications found
Variant links:
Genes affected
WNT2 (HGNC:12780): (Wnt family member 2) This gene is a member of the WNT gene family. The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
CFTR (HGNC:1884): (CF transmembrane conductance regulator) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]
CFTR Gene-Disease associations (from GenCC):
  • cystic fibrosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Orphanet
  • congenital bilateral absence of vas deferens
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary chronic pancreatitis
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.511 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WNT2NM_003391.3 linkc.588+340T>G intron_variant Intron 3 of 4 ENST00000265441.8 NP_003382.1 P09544A0A384MDX3
WNT2NR_024047.2 linkn.593+340T>G intron_variant Intron 3 of 4
LOC105375467XR_007060645.1 linkn.80-7327A>C intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WNT2ENST00000265441.8 linkc.588+340T>G intron_variant Intron 3 of 4 1 NM_003391.3 ENSP00000265441.3 P09544

Frequencies

GnomAD3 genomes
AF:
0.424
AC:
64424
AN:
151884
Hom.:
14009
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.516
Gnomad AMI
AF:
0.266
Gnomad AMR
AF:
0.453
Gnomad ASJ
AF:
0.247
Gnomad EAS
AF:
0.426
Gnomad SAS
AF:
0.468
Gnomad FIN
AF:
0.418
Gnomad MID
AF:
0.380
Gnomad NFE
AF:
0.371
Gnomad OTH
AF:
0.411
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.424
AC:
64518
AN:
152004
Hom.:
14045
Cov.:
32
AF XY:
0.427
AC XY:
31764
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.517
AC:
21428
AN:
41426
American (AMR)
AF:
0.454
AC:
6931
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.247
AC:
858
AN:
3472
East Asian (EAS)
AF:
0.426
AC:
2196
AN:
5152
South Asian (SAS)
AF:
0.467
AC:
2255
AN:
4824
European-Finnish (FIN)
AF:
0.418
AC:
4426
AN:
10576
Middle Eastern (MID)
AF:
0.354
AC:
104
AN:
294
European-Non Finnish (NFE)
AF:
0.371
AC:
25210
AN:
67962
Other (OTH)
AF:
0.411
AC:
867
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1902
3805
5707
7610
9512
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
606
1212
1818
2424
3030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.379
Hom.:
14867
Bravo
AF:
0.427
Asia WGS
AF:
0.481
AC:
1677
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
2.0
DANN
Benign
0.41
PhyloP100
-0.050
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs39312; hg19: chr7-116954785; API